Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AMP Health vs RxION Health

AMP Health
Graded #200

Higher grade

vs+9.699999999999996
RxION Health
Graded #414

Lower grade

The verdict

AMP Health takes it — 66.1/100 to 56.4/100.

AMP Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AMP Health offers compounded semaglutide (injectable and oral) from $199/mo and tirzepatide from $309/mo, plus a $79/mo subscription fee.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAMP Health +15
60
45
Dose & formulationAMP Health +48
88
40
Clinical oversightRxION Health +7
75
82
Labs & monitoringEven
52
52
FulfillmentRxION Health +9
62
71
Contract termsRxION Health +14
41
55
AMP Health · left barRxION Health · right bar

The numbers

MetricAMP HealthRxION Health
WeighScore66.1/10056.4/100
GradeCC
Scorecard rank#200#414
Semaglutide$199/mo (compounded)Not disclosed
Tirzepatide$309/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
AMP Health

Graded #200 · C

Strengths

  • Semaglutide in both injectable and oral formats
  • Tirzepatide available
  • 30-day satisfaction guarantee
  • Personal nutrition plan and health coaching included

Where it loses points

  • $79/mo subscription fee on top of medication ($278–$388/mo total)
  • No visible LegitScript or PCAB accreditation
  • No physical address disclosed
  • States served not disclosed
  • Brand Wegovy listed but out of stock
RxION Health

Graded #414 · C

Strengths

  • LegitScript Certified
  • Offers both semaglutide and tirzepatide, including microdosing
  • HIPAA compliant
  • States its medications are FDA-regulated

Where it loses points

  • No physical address listed
  • No named pharmacy partners
  • Not available to residents of New Jersey, Alaska, or Mississippi

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard